Yuki Shibata
Sapporo, 0600815, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Synthesis and preclinical evaluation of a 68Ga-labeled peptide for PET imaging of transferrin receptor 1 in tumor.
Journal: European journal of nuclear medicine and molecular imaging
Published: June 14, 2025
Impaired oxidative phosphorylation drives primary tumor escape and metastasis.
Journal: bioRxiv : the preprint server for biology
Published: January 20, 2025
Thymidine Phosphorylase Imaging Probe for Differential Diagnosis of Metabolic dysfunction-associated Steatohepatitis.
Journal: Molecular imaging and biology
Published: July 18, 2024
Application of copper (I) selective ligands for PET imaging of reactive oxygen species through metabolic trapping.
Journal: Nuclear medicine and biology
Published: October 17, 2023
Eribulin improves tumor oxygenation demonstrated by 18F-DiFA hypoxia imaging, leading to radio-sensitization in human cancer xenograft models.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 12, 2021
KDM2B promotes cell viability by enhancing DNA damage response in canine hemangiosarcoma.
Journal: Journal of genetics and genomics = Yi chuan xue bao
Published: January 30, 2021
Chitin-Based Double-Network Hydrogel as Potential Superficial Soft-Tissue-Repairing Materials.
Journal: Biomacromolecules
Published: September 16, 2020
Transferrin-based radiolabeled probe predicts the sensitivity of human renal cancer cell lines to ferroptosis inducer erastin.
Journal: Biochemistry and biophysics reports
Published: June 29, 2020
Preclinical investigation of potential use of thymidine phosphorylase-targeting tracer for diagnosis of nonalcoholic steatohepatitis.
Journal: Nuclear medicine and biology
Published: September 05, 2019
Erastin, a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo.
Journal: PloS one
Published: August 01, 2019
High drug efflux pump capacity and low DNA damage response induce doxorubicin resistance in canine hemangiosarcoma cell lines.
Journal: Research in veterinary science
Published: March 02, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026